Description

Gaucher disease is a lysosomal storage disease of glycolipids, with accumulation of glucosylceramide (glucocerebroside). The disease can be divided into different clinical phenotypes based on clinical findings.


 

Major Types:

(1) Type 1 - nonneuronopathic

(2) Type 2 - acute neuronopathic with severe neurologic involvement

(3) Type 3 - subacute neuronopathic

 

Subtypes of Type 3:

(1) Type 3a - progressive neurologic disease with myoclonus and dementia

(2) Type 3b - visceral and skeletal disease with horizontal supranuclear gaze palsy

(3) Type 3c - corneal opacities, cardiac valve calcifications, horizontal supranuclear gaze palsy

Factor

Type 1

Type 2

Type 3a

Type 3b

Type 3c

ethnic group

Ashkenazi Jew

none

northern Swedish

none

none

onset

variable

infancy

childhood

childhood

childhood

hepato-spleno-megaly

mild to severe

mild

severe

severe

mild

bone disease

mild to severe

none

moderate

severe

mild

neurologic disease

none

severe

moderate

none to mild

none

survival if untreated

child to old age

infancy to toddler

early to mid adult

early to mid adult

early to mid adult

after Table 146-1, page 3637.

 


To read more or access our algorithms and calculators, please log in or register.